Ravindra K Pandey
Roswell Park Cancer Institute
USA
Biography
Ravindra K Pandey has worked on investigating the utility of porhyrin-based compounds and nanoparticles (ORMOSIL, polyacrylamide, gold, rHDL, chitosan and polymers) as multifunctional agents for cancer-imaging and therapy. One of the photosensitizers (HPPH) synthesized in his laboratory is currently undergoing phase II human clinical trials for head and neck cancer, and other two candidates which show potential for tumor imaging by PET and near infrared (NIR) fluorescenceguided photodynamic therapy (including surgery) are at the advanced stages of preclinical studies. The current focus of his laboratory is also to explore the use of PDT in combination with other treatment modalities (e. g., surgery and chemotherapy).